中信证券股份有限公司 关于上海凯赛生物技术股份有限公司 向关联方租售公租房的核查意见 中信证券股份有限公司（以下简称"中信证券"或"保荐人"）作为上海凯 赛生物技术股份有限公司（以下简称"凯赛生物"或"公司"）向特定对象发行 A 股股票项目的保荐人，根据《证券发行上市保荐业务管理办法》、《科创板上 市公司持续监管办法（试行）》、《上海证券交易所科创板股票上市规则》以及 《上海证券交易所科创板上市公司自律监管指引第 1 号——规范运作》等有关法 律法规、规范性文件的规定，对凯赛生物向关联方租售公租房的事项进行了审慎 核查，核查情况及核查意见如下： 一、关联交易概述 为吸引和留住优秀人才，增强员工对公司的归属感，提高员工凝聚力及工作 积极性，凯赛生物全资子公司凯赛（上海）生物科技有限公司（以下简称"上海 凯赛"）根据上海市及临港产业园区关于"先租后售"公租房的相关规定，向上 海临港浦江公共租赁住房运营管理有限公司认购公租房，并将其分批租售给公司 员工。 1 何限制转让的情况；标的产权不涉及诉讼、仲裁事项或查封、冻结等司法措施， 也不存在妨碍权属转移的其他情况。 （二）关联方基本情况 本次关联交易涉及公司董事、高级 ...

证券简称：凯赛生物 证券代码：688065 上海荣正企业咨询服务（集团）股份有限公司 关于 上海凯赛生物技术股份有限公司 2025年员工持股计划（草案） 之 独立财务顾问报告 2025 年 9 月 1 | 一、释义 3 | | --- | | 二、声明 4 | | 三、基本假设 5 | | 四、独立财务顾问对本员工持股计划的核查意见 6 | | （一）对本员工持股计划是否符合政策法规规定的核查意见 6 | | （二）对公司实施本员工持股计划可行性的核查意见 7 | | （三）对本员工持股计划定价方式的核查意见 9 | | （四）实施本员工持股计划对公司持续经营能力、是否存在损害上市公司及全体 | | 股东利益的情形的核查意见 10 | | （五）其他应当说明的事项 11 | | 五、备查文件及咨询方式 12 | | （一）备查文件 12 | | （二）咨询方式 12 | 一、释义 本独立财务顾问报告中，除非文义另有所指，下列简称特指如下含义： | 简称 | | 释义 | | --- | --- | --- | | 凯赛生物、公司、本公司 | 指 | 上海凯赛生物技术股份有限公司（含分公司、控股子公 | | | ...

招商证券股份有限公司 关于上海凯赛生物技术股份有限公司 部分募投项目延期的核查意见 招商证券股份有限公司（以下简称"招商证券"、"保荐人"）作为上海凯 赛生物技术股份有限公司（以下简称"凯赛生物"、"上市公司"、"公司"） 持续督导工作的保荐人，根据《证券发行上市保荐业务管理办法》《上海证券交 易所科创板股票上市规则》《科创板上市公司持续监管办法（试行）》《上市公 司募集资金监管规则》《上海证券交易所科创板上市公司自律监管指引第1号— —规范运作》等相关法律、行政法规、部门规章及其他规范性文件的相关规定， 对凯赛生物部分募投项目延期事项进行了审慎核查，并出具如下核查意见： 一、募集资金基本情况 经中国证券监督管理委员会《关于同意上海凯赛生物技术股份有限公司首次 公开发行股票注册的批复》（证监许可〔2020〕1439号）同意注册，公司于2020 年向社会公开发行人民币普通股41,668,198股，每股面值人民币1.00元，每股发行 价为人民币133.45元，合计募集资金人民币556,062.10万元，扣除各项发行费用 （不含增值税）人民币28,062.72万元后，募集资金净额为527,999.38万元。上述 募 ...

中信证券股份有限公司 关于上海凯赛生物技术股份有限公司 部分募投项目延期的核查意见 一、募集资金基本情况 经中国证券监督管理委员会《关于同意上海凯赛生物技术股份有限公司首次 公开发行股票注册的批复》（证监许可[2020]1439号）同意注册，公司于2020年 向社会公开发行人民币普通股41,668,198股，每股面值人民币1.00元，每股发行 价为人民币133.45元，合计募集资金人民币556,062.10万元，扣除各项发行费用 （不含增值税）人民币28,062.72万元后，募集资金净额为527,999.38万元。上述 募集资金已全部到位，并由天健会计师事务所（特殊普通合伙）验证并出具"天 健验[2020]3-68号"《验资报告》。 公司已按相关规定对募集资金进行专户存储，并与保荐人、存放募集资金的 银行签署了募集资金三方监管协议。具体情况详见公司于2020年8月11日披露于 上海证券交易所网站（www.sse.com.cn）的《上海凯赛生物技术股份有限公司首 次公开发行股票科创板上市公告书》。 二、募集资金投资项目情况 根据公司《首次公开发行股票并在科创板上市招股说明书》披露，公司首次 公开发行股票募集资金 ...

上海市锦天城律师事务所 关于上海凯赛生物技术股份有限公司 2025 年员工持股计划（草案）的 法律意见书 地址：上海市浦东新区银城中路 501 号上海中心大厦 9/11/12 层 电话：021-20511000 传真：021-20511999 邮编：200120 上海市锦天城律师事务所 法律意见书 上海市锦天城律师事务所 1 关于上海凯赛生物技术股份有限公司 2025 年员工持股计划（草案）的 法律意见书 致：上海凯赛生物技术股份有限公司 上海市锦天城律师事务所（以下简称"本所"）接受上海凯赛生物技术股份 有限公司（以下简称"公司"或"凯赛生物"）的委托，作为凯赛生物 2025 年 员工持股计划（以下简称"本次员工持股计划"）相关事项的特聘法律顾问，依 据《中华人民共和国证券法》（以下简称"《证券法》"）、《中华人民共和国 公司法》《关于上市公司实施员工持股计划试点的指导意见》（以下简称"《试 点指导意见》"）、《上海证券交易所科创板上市公司自律监管指引第 1 号—— 规范运作》（以下简称"《自律监管指引第 1 号》"）等有关法律、法规和等有 关法律、法规、规范性文件及《上海凯赛生物技术股份有限公司章程》（以 ...

Investment Rating - Industry investment rating: Overweight [1] Core Views - The chemical sector's overall performance ranked 17th this week, with a decline of 0.95%, underperforming the Shanghai Composite Index by 1.16 percentage points and the ChiNext Index by 2.91 percentage points [4][22] - The chemical industry is expected to continue its trend of differentiated growth in 2025, with recommendations to focus on synthetic biology, pesticides, chromatography media, sweeteners, vitamins, light hydrocarbon chemicals, COC polymers, and MDI [4] Summary by Sections Industry Performance - The chemical sector's performance this week was -0.95%, ranking it 17th among all sectors, while the top three performing sectors were power equipment, non-ferrous metals, and electronics [22][23] - The top three individual stocks in the chemical sector this week were Bluefeng Biochemical (61.16%), Shangwei New Materials (44.81%), and Huarsoft Technology (31.83%) [28] Key Industry Dynamics - A new plan for stable growth in the petrochemical industry was released by seven departments, aiming for an average annual growth of over 5% in value added from 2025 to 2026 [34] - The plan emphasizes the importance of technological innovation, digital empowerment, and environmental sustainability in the petrochemical sector [34] Investment Opportunities - Synthetic biology is highlighted as a key area for growth, with companies like Kasei Biotech and Huaheng Biological being recommended for investment [4][8] - The third-generation refrigerants are expected to enter a high prosperity cycle due to upcoming quota policies and stable demand growth from the air conditioning and cold chain markets [5] - The electronic specialty gases market presents significant domestic substitution opportunities, driven by rapid upgrades in the semiconductor and photovoltaic industries [6][8] - Light hydrocarbon chemicals are identified as a global trend, with a shift towards lighter raw materials expected to enhance the value of leading companies in this sector [8] - The COC polymer industry is accelerating its domestic industrialization process, with companies like AkzoNobel being recommended for attention [9] - Potash fertilizer prices are anticipated to rebound as supply tightens and demand increases due to rising agricultural planting intentions [10] - The MDI market is expected to improve due to oligopolistic supply dynamics and stable demand from polyurethane applications [12]

Investment Rating - The report maintains a "Positive" rating for the chemical industry [5][6][20] Core Insights - The petrochemical industry is expected to see stable growth due to the introduction of policies aimed at enhancing industry health and eliminating outdated capacity [5][6] - The demand for viscose filament is anticipated to tighten, leading to an upward trend in prices, while the grass herbicide market is expected to optimize its structure [5][6] - The global GDP growth is projected to remain at 2.8%, with stable oil demand despite some slowdown due to tariff policies [5][6] Industry Dynamics - Oil supply is expected to increase significantly, driven by non-OPEC production, while demand remains stable [5][6] - The coal market is anticipated to experience long-term price stabilization, with easing pressures on downstream sectors [5][6] - Natural gas exports from the U.S. are likely to accelerate, potentially lowering import costs [5][6] Chemical Sector Analysis - The report highlights that the viscose filament industry will see a supply-demand tightening, with a projected increase in operating rates from 84% to over 95% [5][6] - The grass herbicide market is set to address issues of low pricing and quality through upcoming industry meetings aimed at regulating competition [5][6] Investment Recommendations - The report suggests focusing on sectors benefiting from the "anti-involution" policy, including textiles, agriculture, and export-related chemicals [5][6] - Specific companies to watch include Xinxiang Chemical Fiber, Jilin Chemical Fiber, and Lier Chemical, which are expected to benefit from market dynamics [5][6][20] Key Company Valuations - The report provides a valuation table for key companies, indicating various ratings such as "Buy" and "Increase" for companies like Hailir Chemical, Yunnan Chemical, and Wanhu Chemical [20]

Group 1 - The company is developing bio-based composite materials for applications in new energy batteries [1] - The company is simultaneously constructing production lines for these materials [1] - Currently, the materials have not been used for packaging in solid-state batteries [1]

Group 1 - The company is developing bio-based composite materials for applications in new energy battery covers [1] - The company is simultaneously constructing production lines for these materials [1] - Currently, these materials have not been used for the packaging of solid-state batteries [1]

Core Insights - Material innovation is a key driver of modern technological development, with China's new materials industry showing diverse and specialized growth under policy guidance and support [1][2] - The industry is experiencing intensified competition, with companies focusing on differentiated strategies to break through the "involution" phenomenon, emphasizing R&D and high-end breakthroughs as critical approaches [11][12] Industry Development - The new materials sector is characterized by interdisciplinary collaboration, involving materials science, physics, chemistry, and biology, with companies like Nanya New Materials, Huaqin Technology, Lianrui New Materials, and Kaisa Bio focusing on national strategic needs and core technology breakthroughs [2][3] - Nanya New Materials has been a key player in the copper-clad laminate market for 25 years, with products essential for electronic manufacturing, particularly in communications, AI, and automotive sectors [2][3] - Huaqin Technology specializes in aerospace materials and has expanded its offerings to include high-performance composite materials and advanced ceramics, with over 90% of its revenue derived from materials [2][3] Company Strategies - Huaqin Technology has established partnerships with various research institutions to enhance its R&D capabilities and fill domestic technology gaps, achieving significant progress in self-sufficiency [3][6] - Lianrui New Materials focuses on silicon and aluminum-based materials, optimizing product performance through intelligent transformation and entering international supply chains [3][12] - Kaisa Bio has developed bio-based materials, including bio-based nylon, and aims to replace traditional materials in various industries, highlighting its long-standing expertise in the field [4][5] Policy Support - The past five years have seen significant policy support for the copper-clad laminate industry, leading to a reduction in reliance on overseas supply chains and advancements in domestic production capabilities [5][6] - Policies promoting innovation and technology transfer have facilitated the growth of companies like Huaqin Technology, enabling them to expand their product offerings and market reach [6][7] Market Trends - The rise of AI and advancements in bio-manufacturing are accelerating the domestic production of electronic materials and bio-based products, with expectations for the domestic electronic materials market to surpass North America and Europe [8][9] - By 2025, Nanya New Materials anticipates significant growth in output and revenue driven by domestic demand for AI computing power [9][10] - Kaisa Bio is positioned as a global leader in bio-manufacturing, with plans to increase production capacity for long-chain dicarboxylic acids significantly by 2025 [10][11] Competitive Landscape - The new materials industry is witnessing heightened competition, with companies adopting differentiated strategies focused on R&D and high-end product development to maintain market positions [11][12] - Huaqin Technology and Lianrui New Materials are both investing heavily in R&D to secure technological advantages and expand into high-end markets [11][12] - Kaisa Bio emphasizes the importance of balancing technological uniqueness with market demand to achieve stable profitability in the competitive landscape of synthetic biology [13]